Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Insider filings
View:
Post by Mole101 on Mar 05, 2021 8:09am

Insider filings

filings 
2021-03-0504:59
 
2021-03-05
$PMN Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
Warrants
36 - Conversion or exchange
$41,666 
+208,333vol 
$0.20each
1,152,777  
2021-03-0504:57
 
2021-03-05
$PMN Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange

+208,333vol
6,030,644  
2021-03-0504:56
 
2021-03-05
$PMN Cashman, Neil
5 - Senior Officer of Issuer
Direct Ownership
Special Warrants
36 - Conversion or exchange

-208,333vol
0  
Comment by Mole101 on Mar 05, 2021 9:11am
ent filings  2021-03-0505:16   2021-03-05 $PMN Wyman, William Williams 4 - Director of Issuer Direct Ownership Warrants 36 - Conversion or exchange $54,583  +272,916vol  $0.20each 439,582   2021-03-0505:15   2021-03-05  ...more  
Comment by Jamesinvestor1 on Mar 05, 2021 11:49am
Does this mean they're selling or adding to their shares? 
Comment by Haiduk on Mar 05, 2021 3:34pm
The cryptic answer is as follows: "In November, the Company closed on a special warrant financing. The Company issued 13,819,581 special warrant certificates for proceeds of $1,658,350. Each special warrant will be exercisable, without payment of any additional consideration by the holder, into one common share and one transferrable common share purchase warrant (Warrant). Each Warrant will ...more  
Comment by M101 on Mar 05, 2021 4:05pm
Nothing cryptic about the trend of the warrant terms though, Goldstein has gone from 0 warrants to 1/4 for 2 years,1/2 at 2 and then 5 years, and now a full warrant per share for 5 years.  The guy is an absolute failure at financing and a gowing liabiility to the company. His loyalty is now purely Trump level self-interest and everyone who might have considered investing can see it, which ...more  
Comment by Annayya on Mar 05, 2021 7:56pm
This company has no debt to my knowledge, so I think bankruptcy is not a risk at this point at all.
Comment by Mole101 on Mar 05, 2021 11:06pm
They didn't have to exercise those warrants now.. so any cash going into coffers is welcome 
Comment by M101 on Mar 06, 2021 11:23am
True, there's no bankruptcy threat imminent because there is no debt. But we could run out of cash any time and does anyone here seriously believe Gene and Elliot would not shut down operations (again) before gaining their last paycheck?  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities